Self-administration of epinephrine in children: a survey of current prescription practice and recommendations for improvement. by Hughes, J. L. & Stewart, M.
The Ulster Medical Journal, Volume 72, No. 2, pp. 80-85, November 2003.
Self-administration ofepinephrine in children: a survey of
current prescription practice and recommendations for
improvement
JL Hughes, M Stewart
Accepted 1 July 2003
SUMMARY
Theprevalenceofpeanutallergyisincreasingrapidlyandmanychildrenarenowprescribedself-
injectable epinephrine as part oftheir management. We aimed to examine the current extent of
self-injectable epinephrine dispensing to children in the Eastern Health and Social Services
Board (EHSSB), Northern Ireland, including indications for prescription, investigations
performed, information and training provided and actual usage. Dispensing records held by the
EHSSB were examined for the period May to August 1998. All general practitioners prescribing
'Epipens' duringthisperiodwerecontacted andaskedtoidentifythepatientandprovidecontact
details. Information was gathered using postal questionnaires sent to General Practitioners and
parents. A total of 104 'Epipen' prescriptions were dispensed. Thirty-seven (36%) general
practitioners responded to the initial questionnaire; ofthese36 (35%) were suitable foranalysis.
Thirty-four parents were then contacted; 28 (82%) returned questionnaires were reviewed. The
commonest indication for 'Epipen' prescription was peanut allergy (32 of 36 (89%) general
practitioner responses; 25 of28 (89%) parent responses). Twenty-six (72%) children had been
seen by a specialist; all except one had either blood or skin tests. Six of the remaining eight
childrenhadnoinvestigations. Generalpractitioners reported 14(39%)parents tohavebasiclife
support training, compared with six (21%) parents. Eighteen (64%) parents had been given
written information regarding their child's allergy, nine (32%) had been referred to a dietician
and seven (25%) children wore a medical warning bracelet. The Epipen had been used by three
children; all three had multiple food allergies. This study has identified a great variability in the
managementofchildrenwithallergyincludingtheneedforspecialistreferral,furtherinvestigation,
written allergy advice, referral to a dietician and formalised training in basic life support and
administration ofepinephrine. It suggests a lack ofconsensus amongst health care professionals
astothebestpracticeinthemanagementofpotentially lifethreateningfoodallergyandindicates,
at least, a need for better multidisciplinary communication.
INTRODUCTION
Food allergy is common in childhood, with a
prevalence between 0.3% and 8% 1 and the
suggestion that the incidence is increasing.2 In
particular, overthelast 10yearstheprevalenceof
peanut allergy has doubled, and it now affects
approximately 1% ofBritishpreschoolchildren.3
Once a child develops nut allergy it is usually
lifelong,4althoughrecentreportshavechallenged
this idea.5 In the majority ofcases, the diagnosis
has far reaching implications for the child, their
family and carers.
To date there is no consensus on the best
management for achildpresenting with ahistory
suggestive of peanut allergy.6 Guidelines
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London and the Royal College of Pathologists
UK I have recommended that Paediatricians
should always be involved in the care ofchildren
with allergic disease. In individual cases there
may be furtherconsultation with orreferral to an
adultallergyspecialist. Inpeanutallergy,children
presenting with a clear-cut history of an acute
reaction following the ingestion ofpeanuts may
neednoadditionalteststoconfirmthediagnosis,8
but specialist referral is still important for
education ofthe family and child. Children with
a less conclusive history require further
investigations.9 Skin-prick testing and allergen
specific IgE are useful additional tests,'0 but not
diagnostically efficient in all cases. Therefore, a
careful clinical history with judicious use and
interpretation of these tests is required. In some
cases it is necessary to proceedto open ordouble
blind placebo controlled food challenge in order
eithertoconfirmortoexcludefoodallergy. Such
investigations should only be undertaken by
experienced personnel.
This study examined some aspects ofthe current
management of allergy among children by a
questionnairesurveyoftheirgeneralpractitioners
(GPs)andparents.WesurveyedGPsintheEastern
Health and Social Services Board which
commissions care services for approximately
680,000 people. In particular we looked at the
extent ofepinephrine prescription for home use,
in the form of the 'Epipen Autoinjector'. The
indications for prescribing the 'Epipen',
information and training given to parents and
follow-up data on actual usage were obtained.
METHODS
Eastern Health and Social Services Board
dispensing records for a 4 month period from
May 1998 to August 1998 were examined and
GPs prescribing the 'Epipen' were identified.
Priortothis date nocomputercode was available
for 'Epipens', hence GPs could notbe identified.
These GPs were contacted by letter on two
occasionsandaskedtoidentifythechildreceiving
the 'Epipen', complete a short questionnaire on
circumstances surrounding the prescription and
either forward the parent questionnaire to the
family or give permission for the parents to be
approached and return contact information. Two
GPs did not consent to their patient being
approachedandoneparentdidnotwishtobe sent
a questionnaire.
* General Practitioner Questionnaires
GPs were questioned on the indication for the
'Epipen' prescription, either peanut or other
specified allergies, who prescribed the 'Epipen'
and how many were prescribed for each child.
They were also asked to provide information on
investigationsperformed(fullbloodcount(FBC)
and differential white cell count (DWCC), total
IgE, RASTSpecificIgE, skinpricktestingand/or
oral food challenge) and by whom, and what
information was given to parents after the
prescriptionoftheEpipen(recognitionofallergic
reactions, when andhow to use the 'Epipen', and
basic life support (BLS)). Details ofusage ofthe
'Epipen' were also requested. Finally, GPs were
asked to record their perceptions on 'Epipen'
prescription and allergies.
If contact information and consent to approach
the parents was provided, they were contacted in
writing and asked to complete and return a short
questionnaire.
* Parent Questionnaires
Information obtainedfromparentsincludedtheir
perception of why the 'Epipen' was prescribed,
who prescribed it, investigations undertaken,
information andtraining given in therecognition
of allergic reactions, when and how to use the
'Epipen' and BLS. Objective data included the
number of 'Epipens' held by each child, where
they were kept and use to date. Information on
referraltodietician,contactwithschool,provision
ofwritteninformationanduseofMedicalWarning
Bracelet was obtained.
RESULTS
A total of 104 'Epipen' prescriptions were
dispensed by 104 GPs during the four months of
the study. All GPs were contacted and a total of
37 (36%) responded to thequestionnaire. Names
and addresses of two children were not supplied
and one parentdid notconsent, leaving 36(35%)
GP responses for analysis. Thirty-four parents
were sent questionnaires, two were returned as
wrong addresses, one had to be discarded as not
applicable,andthreewerenotreturnedbyparents,
leaving a total of 28 parent questionnaires. The
age range of children involved in this study was
two to 16'/2 years, median age eight years
(information available in 30 cases). There were
19 boys and 15 girls (information available in 34
cases). The commonest indication for 'Epipen'
prescription from GP questionnaires was peanut
allergy (32/36, 89%) either singly (25, 70%) or
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with other allergies (7, 19%). Allergies other
than peanut (egg protein allergy, anaphylaxis to
rabbit fur and a reaction to antibiotics in a child
with cystic fibrosis) accounted for three (8%),
with no information returned in the final case.
The commonest indication for 'Epipen'
prescription from parent responses was peanut
allergy (25/28, 89%) either singly (20, 71%) or
with other allergies (five 8%). Allergies other
thanpeanut (eggprotein, rabbitfurandantibiotic
reaction)accountedfortheremainingthree(11%).
In 23 children, where the GP stated that the
indication for the 'Epipen' prescription was for
peanut allergy alone, parents reported peanut
plus other nut allergies.
General practitioners reported that 11 (31Y%)
'Epipens' were prescribed by a consultant
paediatrician, eight (22%) by an unspecified
hospital consultanteight (22%) by the GP, seven
(19%) by a consultant immunologist and two
(6%) by an unknown source.
General practitioners reported that a total of 26
(72%) children had at least one investigation
performed, more commonly in children referred
to a secondary specialist. Nine children (82%)
prescribed an 'Epipen' by a consultant
paediatrician, six(86%)prescribedbyaconsultant
immunologist and seven (88%) prescribed by an
undefined hospital consultant had at least one
investigation performed, compared to three
children (38%) prescribed an 'Epipen' by their
GP. Six children (17%) had no investigations
performed; fivehad 'Epipens' prescribedbytheir
GP. Investigations performed were not
documented in three cases. The commonest test
orderedwasallergenspecificIgE(n=24/26(92%)
of children who had investigations performed)
and five children were reported to have had oral
food challenge. General Practitioners reported
that 29 (81%) parents had received training in
recognition of allergic reactions, 28 (78%) on
whento use the 'Epipen' and 27(75%) onhowto
use the 'Epipen'. Fourteen (39%) parents were
FABLE
Generalpractitioner andparent responses andpercentage concordance ofresponses
Question asked GP response Parent response % Concordance
Number of respondants 36 28 28
Indication for prescription 82%
Peanut alone 25(69%) 20(71%)
Peanut & other 7(19%) 5(18%)
Other 3(8%) 3(11%)
Prescriber 50%
Consultant paediatrician 11(31%) 5(18%)
Hospital consultant 8(22%) 2(7%)
General practitioner 8(22%) 17(61%)
Consultant immunologist 7(19%) 4(14%)
Unknown 2(6%) 0
Investigations performed 89%
Yes 26 (72%) 22(79%)
No 6 (17%) 6(21%)
Unknown 4 (11%) 0
Training received
Recognition 29(81%) 20(71%) 57%
When 28(78%) 23(82%) 57%
How 27(75%) 23(82%) 54%
BILS 14 (39%) 6 (21%) 36%
Usage 3(8%) 3(11%) 100%
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reported to have been taught BLS. Most parents
reportedreceivinginformationontherecognition
ofallergic reactions (n=20/28, 71%), when tothe
use the 'Epipen' (n=23/28, 82%) and how to use
the 'Epipen' (n=23, 82%). Sixparents (21%) said
they had been trained in BLS.
In only two cases (of 28 where information was
available) was there agreement between GP and
parental responses on information and training
(Table). Thenumberof 'Epipens' ownedby each
child ranged from one to eight. Modal number
was four. Pens were kept at home, in school and
with grandparents. Eighteen (64%) parents said
they have received written information about
allergies, nine (32%) children had been referred
to a dietician and seven (25%) wore a Medical
Warning Bracelet. Twenty-two (85%) schools
hadbeeninformedthatthechildusedan 'Epipen'.
Three(11%of28)childrenprescribedan 'Epipen'
had used it. These children all reported multiple
allergies including peanut allergy, and all had
been admittedtohospital onatleastoneoccasion
following the use of the 'Epipen'. General
Practitioners were asked to record their
perceptionson 'Epipen' prescriptionandallergies.
Thirty (83% of those responding) GPs felt that
the prescription was appropriate. In the cases
where the 'Epipen' was known to be prescribed
following hospital assessment, 21/26 (81%) felt
thattheyhadreceivedadequateinformationfrom
the hospital following the prescription of the
'Epipen'. Overall, four (11%) felt that there was
over-prescription of 'Epipens' to children.
DISCUSSION
Food allergy is common in childhood with a
current prevalence between 0.3% and 8%.'
Increased public and parental awareness, with
high profile media coverage ofthe potential life
threatening complications make it likely that the
demand for home treatment of anaphylaxis will
continuetoincrease.Thisstudynotonlyhighlights
differing perceptions of parents and general
practitionersastowhyan 'Epipen' wasprescribed,
but also a variation in practice. This suggests
poor communication between parents and the
medical professionals. We appreciate that our
study involves small numbers but feel that
importantlessons canbelearntfromourresults if
misinformation and inappropriate management
are to be avoided.
Once a child develops nut allergy it is usually
lifelong, althoughrecentreports havechallenged
this idea.5 Unnecessary dietary restrictions and
lifestyleadaptationscanbeminimizedbyaccurate
diagnosis. The prescription of epinephrine for
home use has resource implications with each
'Epipen' costingjustunder£30, andideally each
child should have a minimum offour prescribed
at the time of diagnosis. The shelf life is often
well under a year, thus making frequent renewal
an added consideration.
Aclearhistoryofanallergicreactionimmediately
followingingestionofpeanuts shouldbeadequate
to make a definitive diagnosis ofpeanut allergy,
but assessment by a specialist is recommended
prior to the prescription ofepinephrine forhome
use.7 In this study we found that one in three
children were not seen by a hospital consultant.
This may be acceptable if the GP involved has
extensive experience in the management of
allergy, but may indicate a lack of awareness of
the need for referral. For children in whom the
historyislesscertain,investigationsareindicated.
Both allergen specific IgE and skin prick testing
have historically been limited by false positive
and negative results but recentreports document
the use of food specific IgE concentrations to
diagnose symptomatic food allergy with 95%
certainty.'3 The gold standard test for children
presentingwithasuspectedfoodallergyisdouble
blindplacebocontrolledfoodchallenge.'415 This
testisnotwithoutriskandmustonlybeperformed
by experienced staff in a centre with full
resuscitation procedures. In this study GPs
reported that 6 (17%) children had no
investigations performed and ofthese 5 were not
referred for assessment by a hospital consultant.
The commonest test performed was allergen
specific IgE (n=24 of26 (92%) that were known
to have investigations performed).
Not all reactions to peanuts are life-threatening,
and oral antihistamines are adequate treatment
for such reactions. However, epinephrine is the
treatment of choice for life threatening
anaphylaxis, but mustbegiven atthe firstsign of
a reaction.6 16 Intramuscular injection is the
preferred route of administration as it provides
rapid peak concentrations in most children.'7
Deficiencies in the actual carriage ofprescribed
epinephrine and its successful usage have been
identified.'8 In astudy of 101 familiespreviously
prescribed epinephrine for food allergy only one
third ofpatients/parents knew how to administer
their epinephrine correctly.'9 When epinephrine
is indicated, it must be available at all times and
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parents and all carers must be trained in the
appropriate timing and safe use of the Epipen.
Complications havebeendescribedfollowingits
use, 12 albeit in the adult population. Despite
this study having small numbers, a relatively
high proportion (3/28 or 11t%) reported using the
Epipen. All three reported receiving instruction
on the use ofthe Epipen butnone on BLS. Again
discrepancies werefoundbetween GPandparent
responses.
Epinephrine administration is only one aspect of
the management of food allergy. Indeed, the
ready access to an Epipen may provide false
reassurance anddecrease vigilance inpreventing
exposure. Our study suggests that professionals
fail to emphasize other aspects of management.
Dietaryavoidanceisakeyaspectofpeanutallergy
management andreferral to a dietician should be
made as peanuts and other nuts are frequent
hidden ingredients in many foodstuffs. Medical
Warning Bracelets allow easy identification of
the medical condition and allow appropriate
treatmenttobegivenearly.Comprehensiveadvice
indrawingupatrainingpackageforanindividual
patient and carers is available and should be
adhered to20 and communicated to parents and
carers.
On the basis of our study results we would
recommend the following:
All children, suspected to have food allergy,
shouldbereferredforspecialistassessmenteither
by a suitably experienced paediatrician or
Immunologist. Testing, when indicated, should
involve the most appropriate and informative
investigation. Review should be arranged to
monitor effectiveness ofavoidance, adequacy of
treatment and continued sensitization.
Ifthe diagnosis is confirmed, amultidisciplinary
team approach should be adopted, and include
* Paediatrician +/- Immunologist
* Dietician
* General practitioner
* School Health Team
The child, theirfamily and othercarers shouldbe
instructed in the recognition and treatment of
allergic reactions including training in basic life
support. Regular review of 'Epipen' and BLS
technique is advisable.
Written information on peanut allergy,
individualized for each child, must be given to
parent and other carers, including schools if of
school age.
Dietary advice on avoidance of nuts or other
relevant food allergens.
Aminimum of4 'Epipens' in the household: two
for home and two for school.
EachchildmustwearaMedicalWarningBracelet
(Medic Alert, SOS) for easy identification of
their medical condition.
CONCLUSION
This study has identified a lack of consensus in
the management of anaphylaxis, including
specialistreferral, investigations, written allergy
advice, referral to a dietician and formalised
training in administration of epinephrine and
basic life support. We recommend the
development and dissemination of clear
guidelines, improved communication between
health professional and carers and continued
evaluation of outcomes.
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